Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Immunoglobulin enhancers increase RNA polymerase 2 stalling at somatic hypermutation target sequences

Alina Tarsalainen, Yaakov Maman, Fei-Long Meng, Minna K. Kyläniemi, Anni Soikkeli, Paulina Budzynska, Jessica J. McDonald, Filip Šenigl, Frederic W. Alt, David G. Schatz, Jukka Alinikula
doi: https://doi.org/10.1101/2021.09.16.460442
Alina Tarsalainen
1Unit of Infections and Immunity, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yaakov Maman
2The Azrieli Faculty of Medicine, Bar Ilan University, Henrietta Szold 8, Safed, 1311502, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fei-Long Meng
3Department of Genetics, Harvard Medical School and Program in Cellular and Molecular Medicine, HHMI, Boston Children’s Hospital, Boston, USA
4State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Minna K. Kyläniemi
1Unit of Infections and Immunity, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland
5Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anni Soikkeli
1Unit of Infections and Immunity, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paulina Budzynska
1Unit of Infections and Immunity, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica J. McDonald
6Department of Immunobiology, Yale School of Medicine, New Haven, CT 06511, USA
7The Annenberg Public Policy Center, 202 S. 36th St., Philadelphia, PA 19104-3806, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Filip Šenigl
8Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20 Praha 4, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederic W. Alt
3Department of Genetics, Harvard Medical School and Program in Cellular and Molecular Medicine, HHMI, Boston Children’s Hospital, Boston, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David G. Schatz
6Department of Immunobiology, Yale School of Medicine, New Haven, CT 06511, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jukka.alinikula@utu.fi david.schatz@yale.edu
Jukka Alinikula
1Unit of Infections and Immunity, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jukka.alinikula@utu.fi david.schatz@yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Somatic hypermutation (SHM) drives the genetic diversity of immunoglobulin (Ig) genes in activated B cells and supports the generation of antibodies with increased affinity for antigen. SHM is targeted to Ig genes by their enhancers (DIVACs; diversification activators), but how the enhancers mediate this activity is unknown. We show using chicken DT40 B cells that highly active DIVACs increase the phosphorylation of RNA polymerase 2 (Pol2) and Pol2 occupancy in the mutating gene with little or no accompanying increase in elongation-competent Pol2 or production of full-length transcripts, indicating accumulation of stalled Pol2. DIVAC has similar effect also in human Ramos Burkitt lymphoma cells. The DIVAC-induced stalling is weakly associated with an increase in the detection of single-stranded DNA bubbles in the mutating target gene. We did not find evidence for antisense transcription, or that DIVAC functions by altering levels of H3K27ac or the histone variant H3.3 in the mutating gene. These findings argue for a connection between Pol2 stalling and cis-acting targeting elements in the context of SHM and thus define a mechanistic basis for locus-specific targeting of SHM in the genome. Our results suggest that DIVAC elements render the target gene a suitable platform for AID-mediated mutation without a requirement for increasing transcriptional output.

Competing Interest Statement

The authors have declared no competing interest.

Footnotes

  • https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE180178

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 17, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Immunoglobulin enhancers increase RNA polymerase 2 stalling at somatic hypermutation target sequences
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Immunoglobulin enhancers increase RNA polymerase 2 stalling at somatic hypermutation target sequences
Alina Tarsalainen, Yaakov Maman, Fei-Long Meng, Minna K. Kyläniemi, Anni Soikkeli, Paulina Budzynska, Jessica J. McDonald, Filip Šenigl, Frederic W. Alt, David G. Schatz, Jukka Alinikula
bioRxiv 2021.09.16.460442; doi: https://doi.org/10.1101/2021.09.16.460442
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Immunoglobulin enhancers increase RNA polymerase 2 stalling at somatic hypermutation target sequences
Alina Tarsalainen, Yaakov Maman, Fei-Long Meng, Minna K. Kyläniemi, Anni Soikkeli, Paulina Budzynska, Jessica J. McDonald, Filip Šenigl, Frederic W. Alt, David G. Schatz, Jukka Alinikula
bioRxiv 2021.09.16.460442; doi: https://doi.org/10.1101/2021.09.16.460442

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Immunology
Subject Areas
All Articles
  • Animal Behavior and Cognition (3686)
  • Biochemistry (7766)
  • Bioengineering (5666)
  • Bioinformatics (21233)
  • Biophysics (10552)
  • Cancer Biology (8157)
  • Cell Biology (11902)
  • Clinical Trials (138)
  • Developmental Biology (6736)
  • Ecology (10387)
  • Epidemiology (2065)
  • Evolutionary Biology (13838)
  • Genetics (9693)
  • Genomics (13054)
  • Immunology (8120)
  • Microbiology (19932)
  • Molecular Biology (7824)
  • Neuroscience (42955)
  • Paleontology (318)
  • Pathology (1276)
  • Pharmacology and Toxicology (2256)
  • Physiology (3350)
  • Plant Biology (7207)
  • Scientific Communication and Education (1309)
  • Synthetic Biology (1998)
  • Systems Biology (5528)
  • Zoology (1126)